SPAG6 and hematologic disorder: In the context of hematological malignancies, Steinbach et al. (2006), Steinbach et al. (2015) verified that SPAG6 expression was increased in patients with AML, whereas SPAG6 expression returned to normal levels in patients with sustained complete remission.